Pharma Journalist - Page 865 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Lundbeck obtains rights to breakthrough research in Alzheimer’s disease

Allergan to Acquire Keller Medical, Inc.,

AbbVie’s rheumatoid arthritis drug succeeds in trial

AstraZeneca enters agreement with Grünenthal to divest rights to migraine treatment Zomig

Lilly Announces Strategic Collaboration with KeyBioscience

Valeant Announces Sale of iNova Pharmaceuticals for $930 Million

Pfizer Receives FDA Fast Track Designation for Tafamidis for Transthyretin Cardiomyopathy

Veloxis Announces Agreement with Chiesi to Commercialize Envarsus XR in China

Novartis drug Tasigna receives EU approval for inclusion of TFR data in product label

NIH researchers find potential genetic cause of Cushing syndrome